23andMe Slashes Workforce By 40%, Ends Therapeutic Programs
The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells. It also has a therapeutic antibody that targets the ULBP6 gene, which suppresses the immune activity of cells.
23andMe cuts 40% of its workforce, discontinues all therapy programs
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki. The company said it is evaluating strategic ...
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.
23andMe cuts 40 per cent of its workforce, discontinues all therapy programs
Genetic testing firm 23andMe said on Monday it is reducing about 40 per cent, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program.
23andMe to cut 40% of workforce, end therapeutics program
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the company announced Monday.
23andMe to slash 40% of workforce as it restructures and shutters therapeutics division
Bay Area genetic testing company 23andMe announced Monday that it plans to lay off 40% of its workforce as part of a broader restructuring effort aimed at cutting costs and refocusing the company on its core business.
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...
FierceBiotech15h
23andMe shutters cancer drug research programs, lays off 40% of staff
We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...
DNA-testing site 23andMe to lay off 40% of its workers
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
pharmaphorum4h
23andMe ends drug development and slashes staff
23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...
STAT1d
The end of 23andMe’s drug discovery dream
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...
newsbytesapp.com5h
DNA-testing site 23andMe is slashing its workforce by 40%
However, 23andMe expects that these measures will eventually save them as much as $35 million. The company's CEO, Anne ...
Pittsburgh Post-Gazette on MSN5d
Nila Bala: The risks of sharing your DNA with online companies aren’t a future concern. They’re here now
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...